Product Description
Brand Qiagen
Model QIAcuity
Capacity 24 & 96 Wells
CAT No 911052
Application Molecular Biology
The QIAcuity is intended for molecular biology applications. This product is not intended for the diagnosis, prevention or treatment of a disease. Therefore, the performance characteristics of the product for clinical use (i.e., diagnostic, prognostic, therapeutic or blood banking) is unknown. For diagnostic applications of digital PCR, please use the QIAcuityDx Digital PCR System.
High-Throughput Digital PCRThe QIAcuity Eight Platform System maximizes laboratory productivity by allowing simultaneous processing of up to eight PCR plates. Its large capacity, combined with rapid cycling and multiplex detection capabilities, makes it exceptionally suited for high-volume nucleic acid quantification projects in diverse laboratory settings.
Unmatched Precision and AutomationFeaturing automated plate calibration, self-cleaning, and walk-away operation, the platform ensures precise results with minimal manual intervention. High-intensity LED excitation, sensitive CMOS imaging, and advanced optical sensors combine for high-definition, reproducible digital PCR results for both routine and complex assays.
Integrated Data Management and Remote AccessEquipped with onboard storage and supporting multiple data formats (.csv, .xls, proprietary), the QIAcuity Software Suite enables synchronized and secure remote control and monitoring. Role-based user authentication and LIMS connectivity support both data integrity and workflow efficiency in regulated environments.
FAQ's of Qiagen QIAcuity Eight Platform System:
Q: How does the QIAcuity Eight Platform System improve digital PCR workflows in high-throughput settings?
A: The system accommodates up to eight 96- or 384-well plates, enabling simultaneous analysis of multiple samples. Its automated calibration, integrated barcode reader, walk-away operation, and high processing capacity significantly streamline workflows and increase sample throughput.
Q: What are the main benefits of using this platform for multiplex digital PCR assays?
A: The QIAcuity Eight offers up to five distinct fluorescent channels for highly accurate multiplex assays. Advanced optics, automated imaging, and real-time data analysis ensure precise quantification, making it suitable for complex diagnostic, research, or pharmaceutical applications.
Q: When is remote monitoring and control of the system recommended?
A: Remote monitoring and control, facilitated via the QIAcuity Software Suite, are ideal when running prolonged experiments or for laboratories managing multiple instruments networked together, enhancing operational flexibility and minimizing hands-on time.
Q: Where can the QIAcuity Eight Platform System be used and what environments are suitable?
A: Designed for research, clinical diagnostics, and pharmaceutical laboratories, the system operates optimally at ambient temperatures of 15C to 30C and relative humidity between 20% to 80%. Its robust build ensures reliable performance in controlled indoor laboratory environments.
Q: What processes does the system automate to reduce manual labor and errors?
A: The platform automates plate calibration, self-cleaning, and error diagnostics. It also features an automated barcode reader and walk-away operation, minimizing manual intervention and reducing the risks of operator error.
Q: How is user access managed on this platform for enhanced data security?
A: Role-based access control is implemented within the system, ensuring that only authorized personnel can access sensitive data and operational features. This approach supports regulatory compliance and maintains data integrity.
Q: What are the power and safety features built into the QIAcuity Eight Platform System?
A: The system operates on 100-240 V AC with electrical protection, automatic shutdown, and advanced error diagnostics to prevent damage. It also includes a low-noise air-cooling system and is constructed from industrial-grade materials for user and equipment safety.